FDA lets device makers hide safety warnings online—not on the box
H.R. 1539 — Medical Device Electronic Labeling Act · Filed by Jay Obernolte (R-CA) · 7 cosponsors · Introduced Feb 24, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill allows medical device manufacturers to provide required labeling information electronically instead of printing it on the device or its packaging, provided the information is easily accessible online and users can request paper copies at no cost. The FDA retains authority to require certain critical safety information remain on the physical label if needed to protect public health.
Why we flagged it
The bill reframes FDA labeling requirements to permit digital-only disclosure for medical devices, reducing manufacturer compliance costs while shifting information-access burden to end users. This is regulatory modernization that favors industry efficiency over point-of-use safety transparency.
What the text implies
- Patients with limited internet access, older adults unfamiliar with digital interfaces, and non-English speakers may face disproportionate difficulty accessing critical safety warnings at the moment of device use.
- Manufacturers gain cost savings from reduced printing and packaging, but users lose the guarantee of immediate, offline access to warnings—shifting liability and information asymmetry toward the company.
The full analysis lists 5 implications of this text.
Who stands to gain
medical device manufacturers; in vitro diagnostic device makers; companies with high labeling/packaging costs